Full Coverage

Nutrition Considerations for Patients With Prostate Cancer, Part 2

redorbit.com
Apr 10, 2008
        
Story Timeline:  227 days

By Meschino, James P NUTRITIONAL AND ANTI-AGING RESEARCH Evidence-Based Adjunctive Nutritional Support 10. ... A recent study showed that 2,000 IU of vitamin D administered daily to 15 patients with prostate cancer helped regulate blood prostate-specific antigen (PSA)... [read full story]                    

Add Comment
Latest article on this story:

Scott & White Hospital Starts Phase II Clinical Trial

 smartbrief.com Apr 11, 2008
First article on this story:

Blocking The Effect Of Inflammation-Causing Cells Lowered Prostate Cancer Cells Invasion

 medicalnewstoday.com Apr 10, 2008
Selected publications with coverage of this story:
redorbit.com misterarticle.com medicalnewstoday.com clevelandclinic.org yahoo.com euroinvestor.co.uk smartbrief.com
RELATED
Found 6 documents:

Scott & White Hospital Starts Phase II Clinical Trial

smartbrief.com
Apr 11, 2008
        

Scott & White has begun recruiting patients with recurring prostate cancer to participate in a clinical trial that uses a PSA (prostate specific antigen) activated chemical injected into the prostate that attaches to prostate cancer cells and causes ...

Cell Genesys says cancer treatment does well in early trial (at bizjournals.com)

yahoo.com
Apr 11, 2008
        

Inc. said Friday its GVAX treatment did well in an early stage clinical test in men with recurrent prostate cancer. The South San Francisco company (NASDAQ: CEGE) is presenting data from this Phase I/II clinical trial at a cancer conference in San Diego today. This trial...

                   

Treatments for Prostate Cancer

clevelandclinic.org
Apr 11, 2008
        

There are several approaches to treating prostate cancer. Here is an overview of the risks and benefits of each of these as well as a peek into newer treatments. ... The traditional approaches to treating prostate cancer are surgery, radiation therapy, watchful waiting,...

                   

Cell Genesys Announces Encouraging Results from Phase 1/2 Trial of GVAX Immunotherapy for...

yahoo.com
Apr 11, 2008
        

SOUTH SAN FRANCISCO, Calif.----Cell Genesys, Inc. today announced data from a completed Phase 1/2 clinical trial of GVAX immunotherapy for prostate cancer in men with recurrent prostate cancer who had not yet received treatment with hormone replacement therapy following relapse after prostate...

How You Can Cure Your Cancer Naturally!

misterarticle.com
Apr 11, 2008
        

Many films about cancer have been made in recent years, the most notable features a scientist who discovers the cure in a South American rain forest, only to lose it; cancer has killed untold millions, but each year the cure for this disease gets another step closer.

Blocking The Effect Of Inflammation-Causing Cells Lowered Prostate Cancer Cells Invasion

medicalnewstoday.com
Apr 10, 2008
        

Recent studies have suggested an association between chronic inflammation and cancers of the prostate, colon, stomach and liver. Now scientists at Northwestern University Feinberg School of Medicine report success in blocking an early step in metastasis of prostate cancer cells by interrupting...